May 12 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* PIRFENIDONE NEWBURY APPROVED BY THE NORWEGIAN HEALTH
AUTHORITIES
* MARKETING AUTHORIZATION (MA) OF PIRFENIDONE NEWBURY 267 &
801 MG
FILM-COATED TABLETS IN NORWAY AS FIRST COUNTRY IN A SCANDINAVIAN
REGISTRATION PROCEDURE
* APPROVALS IN SWEDEN AND DENMARK ARE EXPECTED TO FOLLOW
UPON
FINALIZED NATIONAL REVIEWS
Source text for Eikon: ID:nMFN9kcv1j
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))